Table 2.
Antibiotic resistance within the SCV isolates
| Antibiotic | Nr. of S | %S | Nr. of R | %R |
|---|---|---|---|---|
| Ampicillin | 3 | 17.6 | 14 | 82.4 |
| Penicillin | 3 | 17.6 | 14 | 82.4 |
| Oxacillin | 15 | 88.3 | 2 | 11.7 |
| Amoxicillin/clavulanic acid | 15 | 88,3 | 2 | 11.7 |
| Piperacillin/tazobactam | 15 | 88.3 | 2 | 11.7 |
| Gentamicin | 10 | 58.8 | 7 | 41,2 |
| Tetracyclin | 17 | 100 | 0 | 0 |
| Ciprofloxacin | 16 | 94.1 | 1 | 5.9 |
| Erythromycin | 8 | 47.1 | 9 | 52.9 |
| Clindamycin | 8 | 47.1 | 9 | 52.9 |
| Fusidic acid | 17 | 100 | 0 | 0 |
| Rifampicin | 16 | 94.1 | 0 | 5.9 |
| Linezolid | 17 | 100 | 0 | 0 |
| Vamcomycin | 17 | 100 | 0 | 0 |
| Mupirocin | 17 | 100 | 0 | 0 |
Nr.S number of sensitive isolates, %S percentage of sensitive isolates, Nr of R number of resistant isolates, %R percentage of resistant isolates